AU2003231343A1 - Resistin binding proteins, their preparation and use - Google Patents

Resistin binding proteins, their preparation and use

Info

Publication number
AU2003231343A1
AU2003231343A1 AU2003231343A AU2003231343A AU2003231343A1 AU 2003231343 A1 AU2003231343 A1 AU 2003231343A1 AU 2003231343 A AU2003231343 A AU 2003231343A AU 2003231343 A AU2003231343 A AU 2003231343A AU 2003231343 A1 AU2003231343 A1 AU 2003231343A1
Authority
AU
Australia
Prior art keywords
preparation
binding proteins
resistin
resistin binding
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003231343A
Inventor
Daniela Novick
Menachem Rubinstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Publication of AU2003231343A1 publication Critical patent/AU2003231343A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2003231343A 2002-09-29 2003-05-22 Resistin binding proteins, their preparation and use Abandoned AU2003231343A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL15198002A IL151980A0 (en) 2002-09-29 2002-09-29 Resistin binding proteins, their preparation and use
IL151980 2002-09-29
PCT/IL2003/000429 WO2004028555A1 (en) 2002-09-29 2003-05-22 Resistin binding proteins, their preparation and use

Publications (1)

Publication Number Publication Date
AU2003231343A1 true AU2003231343A1 (en) 2004-04-19

Family

ID=29596524

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003231343A Abandoned AU2003231343A1 (en) 2002-09-29 2003-05-22 Resistin binding proteins, their preparation and use

Country Status (3)

Country Link
AU (1) AU2003231343A1 (en)
IL (1) IL151980A0 (en)
WO (1) WO2004028555A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100423781C (en) * 2006-08-09 2008-10-08 郭锡熔 Application of Resistin binding polypeptide for preparing medicine promoting insulin secretion
CN112904012B (en) * 2019-12-04 2023-01-17 张曼 Application of urine IGKC protein and polypeptide fragment thereof in normal pregnancy or gestational diabetes
CN115372482A (en) * 2021-05-17 2022-11-22 上海交通大学医学院附属仁济医院 Application of intestinal flora spectrum and metabolic markers in preparation of polycystic ovarian syndrome diagnostic kit

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19850015A1 (en) * 1998-10-30 2000-05-04 Max Delbrueck Centrum Proteins of the stomatin family and their use as target proteins for ore therapy
ATE525390T1 (en) * 1999-04-27 2011-10-15 Univ Pennsylvania USE OF RESISTANT SPECIFIC ANTIBODIES IN THE TREATMENT OF DIABETES

Also Published As

Publication number Publication date
IL151980A0 (en) 2003-04-10
WO2004028555A1 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
AU2002247826A1 (en) Specific binding members
WO2004031211A8 (en) Hla binding peptides and their uses
AU2003273000A1 (en) Stable solid preparations
AU2003209272A1 (en) Engineered binding proteins
AU2003248721A1 (en) Adsorbents, methods of preparation, and methods of use thereof
AU2002253738A1 (en) Secure file transfer
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2002336658A1 (en) Il-4 mutein proteins, antibodies, compositions, methods and uses
WO2004003149A8 (en) Cngh0005 polypeptides, antibodies, compositions, methods and uses
AU2003226899A1 (en) Human diabetes-mediating proteins
AU2002365269A1 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
AU2003217565A1 (en) Polydioxaborines, their monomers and their preparation
AU2003285892A1 (en) Bace binding peptides and uses thereof
AU2002341828A1 (en) Enhanced proteins and methods for their use
AU2003231343A1 (en) Resistin binding proteins, their preparation and use
AU2003231342A1 (en) Resistin binding proteins, their preparation and use
AU2003220557A1 (en) Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses
AU2003271854A1 (en) Composition comprising proteinaceous material, its preparation and use
AU2003299336A1 (en) Diphosphines, preparation and uses thereof
AUPS036402A0 (en) Rhamnose binding protein
AU2003202694A1 (en) Torero protein
AU2003270055A1 (en) Neurotransmission-associated proteins
AU2003278718A1 (en) Stars-a muscle-specification-binding protein
AU2003292774A1 (en) Novel proteins and use thereof
AU2003280992A1 (en) Novel proteins and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase